M05.29

Clinical Causes: Persistent inflammation from rheumatoid arthritis weakens blood vessel walls, leading to vasculitis. Autoimmune processes where the immune system mistakenly attacks blood vessels. Genetic factors that predispose individuals to autoimmune and vascular complications. Environmental triggers such as infections or exposure to certain chemicals may contribute. Poorly controlled or advanced rheumatoid arthritis increases the risk of vasculitis development.

Key Symptoms: Skin changes, including rashes, ulcers, or tender nodules. Pain or numbness in affected tissues, often in the extremities. Increased fatigue and malaise due to systemic inflammation. Joint swelling, tenderness, or stiffness common in RA, often exacerbated. Weakness or loss of sensation in limbs, caused by nerve involvement. Fever and weight loss in more severe or widespread cases. Signs of organ involvement, such as shortness of breath or chest pain if lungs are affected. Palpable purpura or discoloration of the skin due to blood vessel inflammation.

Diagnosis Path: Detailed medical history and physical examination focusing on skin, joints, and neurological signs. Blood tests such as rheumatoid factor (RF), anti-CCP antibodies, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) to assess inflammation and autoimmune activity. Imaging techniques like X-rays, ultrasound, or MRI to evaluate joint and tissue involvement. Biopsy of skin or affected tissues to confirm blood vessel inflammation. Assessing organ function if systemic symptoms suggest internal organ involvement.

Treatment Protocols: Immunosuppressive medications such as corticosteroids to reduce inflammation. Disease-modifying antirheumatic drugs (DMARDs), like methotrexate or cyclophosphamide, to modulate immune response. Biologic agents targeting specific immune system components may be prescribed in severe cases. Supportive therapies like wound care for skin ulcers and physical therapy to maintain joint function. Monitoring for side effects of medications and regular assessment of disease activity. Managing cardiovascular risk factors and comorbidities to improve overall health outcomes.